학술논문
Intravenous 5-fluoro-2'-deoxycytidine administered with tetrahydrouridine increases the proportion of p16-expressing circulating tumor cells in patients with advanced solid tumors.
Document Type
Journal Article
Author
Coyne, Geraldine O.'Sullivan; Wang, Lihua; Zlott, Jennifer; Juwara, Lamin; Covey, Joseph M.; Beumer, Jan H.; Cristea, Mihaela C.; Newman, Edward M.; Koehler, Stephen; Nieva, Jorge J.; Garcia, Agustin A.; Gandara, David R.; Miller, Brandon; Khin, Sonny; Miller, Sarah B.; Steinberg, Seth M.; Rubinstein, Larry; Parchment, Ralph E.; Kinders, Robert J.; Piekarz, Richard L.
Source
Subject
*TUMOR suppressor genes
*CIRCULATING tumor DNA
*TRANSITIONAL cell carcinoma
*TUMOR suppressor proteins
*NON-small-cell lung carcinoma
*DNA methyltransferases
*TUMORS
*PROTEIN analysis
*PHARMACOGENOMICS
*RESEARCH
*INTRAVENOUS therapy
*CLINICAL trials
*NUCLEOSIDES
*CYTOMETRY
*RESEARCH methodology
*METASTASIS
*DEOXYCYTIDINE
*ANTINEOPLASTIC agents
*EVALUATION research
*MEDICAL cooperation
*CANCER
*URINARY organs
*COMPARATIVE studies
*GENES
*RESEARCH funding
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0344-5704
Abstract